HSD17B3
Basic information
Region (hg38): 9:96235306-96302176
Links
Phenotypes
GenCC
Source:
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency (Strong), mode of inheritance: AR
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
17-Beta hydroxysteroid dehydrogenase III deficiency | AR | Endocrine; Genitourinary | Prepubertal diagnosis may allow surgical treatment via removal of abnormal testes, preventing typical presenting clinical signs in puberty (marked masculinization and hirsutism) | Endocrine; Genitourinary | 2998649; 8075637; 8550739; 10599740; 21700882; 22212252; 22594312; 22445608; 22876557 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (20 variants)
- Testosterone 17-beta-dehydrogenase deficiency (10 variants)
- Pseudohermaphroditism (5 variants)
- Inborn genetic diseases (3 variants)
- HSD17B3-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HSD17B3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 62 | 64 | ||||
missense | 21 | 40 | ||||
nonsense | 9 | |||||
start loss | 0 | |||||
frameshift | 8 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 9 | |||||
splice region | 1 | 4 | 19 | 1 | 25 | |
non coding | 76 | 37 | 117 | |||
Total | 20 | 20 | 29 | 141 | 39 |
Highest pathogenic variant AF is 0.000355
Variants in HSD17B3
This is a list of pathogenic ClinVar variants found in the HSD17B3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-96235312-G-T | Testosterone 17-beta-dehydrogenase deficiency | Uncertain significance (Jan 13, 2018) | ||
9-96235459-G-A | Testosterone 17-beta-dehydrogenase deficiency | Uncertain significance (Apr 28, 2017) | ||
9-96235465-T-G | HSD17B3-related disorder | Likely benign (Jun 18, 2019) | ||
9-96235470-T-G | Uncertain significance (Oct 31, 2022) | |||
9-96235471-T-A | Uncertain significance (May 16, 2022) | |||
9-96235499-G-A | Likely benign (Jan 22, 2024) | |||
9-96235513-G-A | Testosterone 17-beta-dehydrogenase deficiency | Conflicting classifications of pathogenicity (Dec 11, 2023) | ||
9-96235520-G-A | Likely benign (Feb 24, 2023) | |||
9-96235528-C-T | not specified • Testosterone 17-beta-dehydrogenase deficiency | Benign/Likely benign (Feb 01, 2024) | ||
9-96235529-G-A | Likely benign (Jan 17, 2024) | |||
9-96235541-C-T | Likely pathogenic (May 23, 2023) | |||
9-96235542-C-T | Likely pathogenic (May 30, 2023) | |||
9-96235547-C-G | Likely benign (May 26, 2023) | |||
9-96235547-C-T | Likely benign (Dec 29, 2023) | |||
9-96235548-G-A | Pseudohermaphroditism • Testosterone 17-beta-dehydrogenase deficiency • Inborn genetic diseases | Pathogenic/Likely pathogenic (Jun 26, 2024) | ||
9-96235553-C-T | Likely benign (Dec 09, 2023) | |||
9-96235556-G-A | Likely benign (Jan 31, 2024) | |||
9-96235562-A-G | Likely benign (Feb 21, 2023) | |||
9-96235565-G-A | Likely benign (Jan 19, 2023) | |||
9-96235569-G-A | Uncertain significance (Sep 24, 2021) | |||
9-96235581-G-A | Likely benign (May 28, 2023) | |||
9-96235582-A-G | Likely benign (Dec 30, 2022) | |||
9-96235586-G-A | Likely benign (May 10, 2023) | |||
9-96235628-ATCTTTGTGG-A | Benign (Aug 09, 2018) | |||
9-96240473-C-G | Benign (Aug 09, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HSD17B3 | protein_coding | protein_coding | ENST00000375263 | 11 | 66847 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.49e-7 | 0.760 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.367 | 155 | 168 | 0.920 | 0.00000966 | 2001 |
Missense in Polyphen | 49 | 53.89 | 0.90927 | 664 | ||
Synonymous | 0.568 | 63 | 69.0 | 0.913 | 0.00000446 | 613 |
Loss of Function | 1.28 | 12 | 17.8 | 0.673 | 7.76e-7 | 219 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000508 | 0.000508 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Favors the reduction of androstenedione to testosterone. Uses NADPH while the two other EDH17B enzymes use NADH. {ECO:0000269|PubMed:26545797}.;
- Pathway
- Steroid hormone biosynthesis - Homo sapiens (human);17-Beta Hydroxysteroid Dehydrogenase III Deficiency;Androgen and Estrogen Metabolism;Aromatase deficiency;Androgen Receptor Network in Prostate Cancer;Steroid Biosynthesis;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Metabolism;Fatty acid metabolism;Androgen biosynthesis;Metabolism of steroid hormones;Metabolism of steroids;androgen biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;superpathway of steroid hormone biosynthesis;Steroid hormones
(Consensus)
Recessive Scores
- pRec
- 0.219
Intolerance Scores
- loftool
- 0.229
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 42.06
Haploinsufficiency Scores
- pHI
- 0.122
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0330
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hsd17b3
- Phenotype
Gene ontology
- Biological process
- steroid biosynthetic process;androgen biosynthetic process;male genitalia development;oxidation-reduction process;testosterone biosynthetic process
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;intracellular membrane-bounded organelle
- Molecular function
- testosterone dehydrogenase [NAD(P)] activity;testosterone 17-beta-dehydrogenase (NADP+) activity